<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<doc>
  <docno>
    <textblock>FR940128-0-00033</textblock>
  </docno>
  <parent>
    <textblock>FR940128-0-00009</textblock>
  </parent>
  <text>
    <textblock>Listing of Color Additives for Coloring Sutures; D&amp;C Violet No. 2; Confirmation of Effective Date</textblock>
  </text>
  <usdept>
    <textblock>DEPARTMENT OF HEALTH AND HUMAN SERVICES</textblock>
  </usdept>
  <usbureau>
    <textblock>Food and Drug Administration</textblock>
  </usbureau>
  <cfrno>
    <textblock>21 CFR Part 74</textblock>
  </cfrno>
  <rindock>
    <textblock>[Docket No. 91C-0432]</textblock>
  </rindock>
  <agency>
    <textblock>AGENCY:</textblock>
    <textblock>Food and Drug Administration, HHS.</textblock>
  </agency>
  <action>
    <textblock>ACTION:</textblock>
    <textblock>Final rule; confirmation of effective date.</textblock>
  </action>
  <summary>
    <textblock>SUMMARY:</textblock>
    <textblock>The Food and Drug Administration (FDA) is confirming the effective date of December 16, 1993, for the final rule that amended the color additive regulations to provide for the safe use of D&amp;C Violet No. 2 to color poliglecaprone 25 (</textblock>
    <textblock>e</textblock>
    <textblock>-caprolactone/glycolide copolymer) absorbable sutures for general surgery.</textblock>
  </summary>
  <date>
    <textblock>DATES:</textblock>
    <textblock>Effective date confirmed: December 16, 1993.</textblock>
  </date>
  <further>
    <textblock>FOR FURTHER INFORMATION CONTACT:</textblock>
    <textblock>Mitchell A. Cheeseman, Center for Food Safety and Applied Nutrition (HFS-216), Food and Drug Administration, 200 C St. SW., Washington, DC 20204, 202-254-9511.</textblock>
  </further>
  <supplem>
    <textblock>SUPPLEMENTARY INFORMATION:</textblock>
    <textblock>In the</textblock>
    <textblock>Federal Register</textblock>
    <textblock>of November 15, 1993 (58 FR 60106), FDA amended 21 CFR 74.3602 to provide for the safe use of D&amp;C Violet No. 2 to color poliglecaprone 25 (</textblock>
    <textblock>e</textblock>
    <textblock>-caprolactone/glycolide copolymer) absorbable sutures for general surgery.</textblock>
    <textblock>FDA gave interested persons until December 16, 1993, to file objections or requests for a hearing. The agency received no objections or requests for a hearing on the final rule. Therefore, FDA finds that the final rule published in the</textblock>
    <textblock>Federal Register</textblock>
    <textblock>of November 15, 1993, should be confirmed.</textblock>
    <textblock>List of Subjects in 21 CFR Part 74</textblock>
    <textblock>Color additives, Cosmetics, Drugs.</textblock>
    <textblock>Therefore, under the Federal Food, Drug, and Cosmetic Act (secs. 201, 401, 402, 403, 409, 501, 502, 505, 601, 602, 701, 721 (21 U.S.C. 321, 341, 342, 343, 348, 351, 352, 355, 361, 362, 371, 379e)) and under authority delegated to the Commissioner of Food and Drugs (21 CFR 5.10), notice is given that no objections or requests for a hearing were filed in response to the November 15, 1993, final rule. Accordingly, the amendments promulgated thereby became effective December 16, 1993.</textblock>
    <textblock>Dated: January 24, 1994.</textblock>
  </supplem>
  <signer>
    <textblock>Michael R. Taylor,</textblock>
  </signer>
  <signjob>
    <textblock>Deputy Commissioner for Policy.</textblock>
  </signjob>
  <frfiling>
    <textblock>[FR Doc. 94-1885 Filed 1-27-94; 8:45 am]</textblock>
  </frfiling>
  <billing>
    <textblock>BILLING CODE 4160-01-F</textblock>
  </billing>
</doc>
